By Peter Geschek : Palbociclib Pfizer 's ( PFE ) palbociclib is an oral CDK (cyclin-dependent kinase) 4 and 6 inhibitor. Among post-menopausal women with advanced breast
Sun Pharma diabetes tablets were found with an epilepsy medication, while Ranbaxy pulled two batches of its version of Pfizer 's Lipitor cholesterol drug. The recalls come amid increasing scrutiny of generic drugs manufactured in India and of
By PFE ) fares in the ModernGraham valuation model. PFE data by YCharts Defensive Investor - must pass at least 6 of the following 7 tests: Score = 4/7 Adequate Size of Enterprise - market capitalization of at least $2 billion - PASS Sufficiently
their regulatory filings that the appearance of these side effects could delay or stop the product's development. Pfizer ( PFE ) and Amgen ( AMGN ) are also working on PCSK9 inhibitors. 1 comment!
giving SPPI the opportunity to price high. The company has various partnerships for both development and marketing: Pfizer /Takeda for Fusilev, Bayer for Zevalin, Topotarget for Belinostat and Allergan for Apaziquone. Moreover, OncoRx is
and cancer. AQXP has no collaboration partners and most of its intellectual property is licensed. Pfizer ( PFE ) owns 16.5% pre-IPO. PFE has a market cap of $208 billion. "Certain of our directors and existing stockholders, or their
Pfizer ( PFE ) voluntarily recalls two lots of Effexor XR (venlafaxine HCL) and one lot of Greenstone LLC-branded Venlafaxine HCL in response
March 6 (Reuters) - Pfizer Inc said on Thursday it was recalling two lots of its Effexor XR antidepressant and another lot of its generic version of the drug after a pharmacist reported finding one capsule of a different medicine in a bottle of Effexor.
portrayal of a marketing strategy. A perfect example is Pfizer 's ( PFE ) little blue pill, Viagra. Looking ahead, I believe ..... market. Viagra Success Story: A Marketing Tale In 2012, Pfizer 's Viagra accounted for the largest share , 45%, of
Pfizer ( PFE ) is proceeding with plans to commercialize an over-the-counter version ..... has already rejected Merck's ( MRK ) plans to do the same with Mevacor. Pfizer believes that it will be successful by virtue of "new and creative" ways